{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:09:18Z","timestamp":1789985358954,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Macrophage activation syndrome (MAS) has been reported in association with many rheumatic diseases, most commonly in systemic juvenile rheumatoid arthritis (sJRA). Clinically, MAS is similar to hemophagocytic lymphohistiocytosis (HLH), a genetic disorder with absent or depressed natural killer (NK) function. We have previously reported that, as in HLH, patients with MAS have profoundly decreased NK activity, suggesting that this abnormality might be relevant to the pathogenesis of the syndrome. Here we examined the extent of NK dysfunction across the spectrum of diseases that comprise juvenile rheumatoid arthritis (JRA). Peripheral blood mononuclear cells (PBMC) were collected from patients with pauciarticular (<jats:italic>n<\/jats:italic> = 4), polyarticular (<jats:italic>n<\/jats:italic> = 16), and systemic (<jats:italic>n<\/jats:italic> = 20) forms of JRA. NK cytolytic activity was measured after co-incubation of PBMC with the NK-sensitive K562 cell line. NK cells (CD56<jats:sup>+<\/jats:sup>\/T cell receptor [TCR]-\u03b1\u03b2<jats:sup>-<\/jats:sup>), NK T cells (CD56<jats:sup>+<\/jats:sup>\/TCR-\u03b1\u03b2<jats:sup>+<\/jats:sup>), and CD8<jats:sup>+<\/jats:sup> T cells were also assessed for perforin and granzyme B expression by flow cytometry. Overall, NK cytolytic activity was significantly lower in patients with sJRA than in other JRA patients and controls. In a subgroup of patients with predominantly sJRA, NK cell activity was profoundly decreased: in 10 of 20 patients with sJRA and in only 1 of 20 patients with other JRA, levels of NK activity were below two standard deviations of pediatric controls (<jats:italic>P<\/jats:italic> = 0.002). Some decrease in perforin expression in NK cells and cytotoxic T lymphocytes was seen in patients within each of the JRA groups with no statistically significant differences. There was a profound decrease in the proportion of circulating CD56<jats:sup>bright<\/jats:sup> NK cells in three sJRA patients, a pattern similar to that previously observed in MAS and HLH. In conclusion, a subgroup of patients with JRA who have not yet had an episode of MAS showed decreased NK function and an absence of circulating CD56<jats:sup>bright<\/jats:sup> population, similar to the abnormalities observed in patients with MAS and HLH. This phenomenon was particularly common in the systemic form of JRA, a clinical entity strongly associated with MAS.<\/jats:p>","DOI":"10.1186\/ar1453","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T07:29:58Z","timestamp":1100158198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":208,"title":["Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome"],"prefix":"10.1186","volume":"7","author":[{"given":"Joyce","family":"Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray H","family":"Passo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Filipovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei A","family":"Grom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,10]]},"reference":[{"key":"1335_CR1","first-page":"451","volume":"11","author":"JL Stephan","year":"1993","unstructured":"Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM: Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol. 1993, 11: 451-456.","journal-title":"Clin Exp Rheumatol"},{"key":"1335_CR2","first-page":"121","volume":"20","author":"BH Athreya","year":"2002","unstructured":"Athreya BH: Is macrophage activation syndrome a new entity?. Clin Exp Rheumatol. 2002, 20: 121-123.","journal-title":"Clin Exp Rheumatol"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","volume":"15","author":"AA Grom","year":"2003","unstructured":"Grom AA: Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?. Curr Opin Rheumatol. 2003, 15: 587-590. 10.1097\/00002281-200309000-00011.","journal-title":"Curr Opin Rheumatol"},{"key":"1335_CR4","first-page":"2513","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV, Schneider R: Macrophage activation syndrome \u2013 what's in a name!. J Rheumatol. 2003, 30: 2513-","journal-title":"J Rheumatol"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S0022-3476(83)80704-5","volume":"103","author":"ED Silverman","year":"1983","unstructured":"Silverman ED, Miller JJ, Bernstein B, Shafai T: Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr. 1983, 103: 872-876.","journal-title":"J Pediatr"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF02041564","volume":"2","author":"A De Vere-Tyndall","year":"1983","unstructured":"De Vere-Tyndall A, Macauley D, Ansell B: Disseminated intravascular coagulation complicating systemic juvenile rheumatoid arthritis ('Still's disease'). Clin Rheumatol. 1983, 2: 415-418.","journal-title":"Clin Rheumatol"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","volume":"106","author":"M Hadchouel","year":"1985","unstructured":"Hadchouel M, Prieur AM, Griscelli C: Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr. 1985, 106: 561-566.","journal-title":"J Pediatr"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-3476(96)70408-0","volume":"128","author":"A Ravelli","year":"1996","unstructured":"Ravelli A, De Benedetti F, Viola S, Martini A: Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr. 1996, 128: 275-278.","journal-title":"J Pediatr"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0022-3476(96)70140-3","volume":"129","author":"AA Grom","year":"1996","unstructured":"Grom AA, Passo M: Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr. 1996, 129: 630-632.","journal-title":"J Pediatr"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawney","year":"2001","unstructured":"Sawney S, Woo P, Murray K: Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001, 85: 421-426. 10.1136\/adc.85.5.421.","journal-title":"Arch Dis Child"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","volume":"40","author":"JL Stephan","year":"2001","unstructured":"Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prier AM: Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology (Oxford). 2001, 40: 1285-1292.","journal-title":"Rheumatology (Oxford)"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00043426-199611000-00002","volume":"18","author":"RM Egeler","year":"1996","unstructured":"Egeler RM, Shapiro R, Loechelt B, Filipovich AH: Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 1996, 18: 340-345. 10.1097\/00043426-199611000-00002.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1203\/00006450-199810000-00001","volume":"44","author":"KE Sullivan","year":"1998","unstructured":"Sullivan KE, Delaat CA, Douglas SD, Filipovich AH: Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res. 1998, 44: 465-468.","journal-title":"Pediatr Res"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.V99.1.61","volume":"99","author":"K Kogawa","year":"2002","unstructured":"Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH: Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002, 99: 61-66. 10.1182\/blood.V99.1.61.","journal-title":"Blood"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","volume":"286","author":"SE Stepp","year":"1999","unstructured":"Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, et al: Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999, 286: 1957-1959. 10.1126\/science.286.5446.1957.","journal-title":"Science"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0167-5699(00)01622-4","volume":"21","author":"SE Stepp","year":"2000","unstructured":"Stepp SE, Mathew PA, Bennett M, de Saint Basile G, Kumar V: Perforin: more than just an effector molecule. Immunol Today. 2000, 21: 254-256. 10.1016\/S0167-5699(00)01622-4.","journal-title":"Immunol Today"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1067\/mpd.2003.110","volume":"142","author":"AA Grom","year":"2003","unstructured":"Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich AH: Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003, 142: 292-296. 10.1067\/mpd.2003.110.","journal-title":"J Pediatr"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/art.1780290216","volume":"29","author":"JT Cassidy","year":"1986","unstructured":"Cassidy JT, Levinson JKE, Bass JC, Baum J, Brewer EJ, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986, 29: 274-281.","journal-title":"Arthritis Rheum"},{"key":"1335_CR19","first-page":"214","volume-title":"Textbook of Pediatric Rheumatology","author":"JT Cassidy","year":"2001","unstructured":"Cassidy JT, Petty RE: Textbook of Pediatric Rheumatology. 2001, Philadelphia: W.B. Saunders Company, 214-217."},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0889-857X(02)00016-9","volume":"28","author":"R Schneider","year":"2002","unstructured":"Schneider R, Passo MH: Juvenile rheumatoid arthritis. Rheum Dis Clin North Am. 2002, 28: 503-530. 10.1016\/S0889-857X(02)00016-9.","journal-title":"Rheum Dis Clin North Am"},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jmg.2003.011528","volume":"41","author":"S Molleran Lee","year":"2004","unstructured":"Molleran Lee S, Villanueva J, Sumegi J, Zhang K, Kogawa K, Davis J, Filipovich AH: Characterization of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet. 2004, 41: 137-144. 10.1136\/jmg.2003.013003.","journal-title":"J Med Genet"},{"key":"1335_CR22","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.4049\/jimmunol.132.6.2876","volume":"132","author":"MP Nair","year":"1984","unstructured":"Nair MP, Schwartz SA: Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes. J Immunol. 1984, 132: 2876-2882.","journal-title":"J Immunol"},{"key":"1335_CR23","first-page":"239","volume":"20","author":"CHP Wouters","year":"2002","unstructured":"Wouters CHP, Ceuppens JL, Stevens EAM: Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis. Clin Exp Rheumatol. 2002, 20: 239-248.","journal-title":"Clin Exp Rheumatol"},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer cell subsets. Trends Immunol. 2001, 22: 633-640. 10.1016\/S1471-4906(01)02060-9.","journal-title":"Trends Immunol"},{"key":"1335_CR25","first-page":"200","volume":"43","author":"J Villanueva","year":"2004","unstructured":"Villanueva J, Filipovich A, Lee S, Passo MH, Grom AA: Natural killer cell function and perforin expression in patients with systemic onset juvenile rheumatoid arthritis as compared to macrophage activation syndrome and hemophagocytic lymphohistiocytosis [abstract]. Pediatr Blood Cancer. 2004, 43: 200-","journal-title":"Pediatr Blood Cancer"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","volume":"42","author":"NM Wulffraat","year":"2003","unstructured":"Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W: Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford). 2003, 42: 375-379.","journal-title":"Rheumatology (Oxford)"},{"key":"1335_CR27","first-page":"S406","volume":"43","author":"NJ Normand","year":"2000","unstructured":"Normand NJ, Lehman TJA, Elkon KB, Onel KB: Lower expression of perforin in CD8+ T cells of patients with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000, 43: S406-","journal-title":"Arthritis Rheum"},{"key":"1335_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916930290005864","volume":"35","author":"AG Baxter","year":"2002","unstructured":"Baxter AG, Smyth MJ: The role of NK cells in autoimmune disease. Autoimmunity. 2002, 35: 1-14. 10.1080\/08916930290005864.","journal-title":"Autoimmunity"},{"key":"1335_CR29","first-page":"171","volume":"23","author":"A Yabuhara","year":"1996","unstructured":"Yabuhara A, Yang FC, Nakazawa T, Iwasaki Y, Mori T, Koike K, Kawa H, Komiyama A: A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol. 1996, 23: 171-177.","journal-title":"J Rheumatol"},{"key":"1335_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.11368","volume":"49","author":"R Dhote","year":"2003","unstructured":"Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, et al: Reactive hemophagocytic syndrome in adult systemic disease: report of 26 cases and literature review. Arthritis Rheum. 2003, 49: 633-639. 10.1002\/art.11368.","journal-title":"Arthritis Rheum"},{"key":"1335_CR31","volume-title":"Blood","author":"E Carbone","year":"2004","unstructured":"Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V, Spies T, Pollio G, Cosman D, et al: HLA Class I, NKG2D and natural cytotoxicity receptors regulate mutliple myeloma cell recognition by natural killer cells. Blood. 2004,"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1046\/j.1365-2141.2001.02936.x","volume":"114","author":"M Arico","year":"2001","unstructured":"Arico M, Danesino C, Pende D, Moretta L: Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001, 114: 761-769. 10.1046\/j.1365-2141.2001.02936.x.","journal-title":"Br J Haematol"},{"key":"1335_CR33","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1","volume":"31","author":"HC Su","year":"2001","unstructured":"Su HC, Nguyen KB, Salazar-Mather TP, Ruzek MC, Dalod MY, Biron CA: NK cell functions restrain T cell resonses during viral infections. Eur J Immunol. 2001, 31: 3048-3055. 10.1002\/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1.","journal-title":"Eur J Immunol"},{"key":"1335_CR34","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.4049\/jimmunol.161.12.7063","volume":"161","author":"J Spielman","year":"1998","unstructured":"Spielman J, Lee RK, Podack ER: Perforin\/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol. 1998, 161: 7063-7070.","journal-title":"J Immunol"},{"key":"1335_CR35","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1128\/JVI.73.3.2527-2536.1999","volume":"73","author":"M Matloubian","year":"1999","unstructured":"Matloubian M, Suresh M, Glass A, Galvan M, Chow K, Whitmire JK, Walsh CM, Clark WR, Ahmed R: A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol. 1999, 73: 2527-2536.","journal-title":"J Virol"},{"key":"1335_CR36","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","volume":"290","author":"VP Badovinac","year":"2000","unstructured":"Badovinac VP, Tvinnereim AR, Harty JT: Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science. 2000, 290: 1354-1358. 10.1126\/science.290.5495.1354.","journal-title":"Science"},{"key":"1335_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.it.2003.10.012","volume":"25","author":"MA Cooper","year":"2004","unstructured":"Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA: NK cell and DC interactions. Trends Immunol. 2004, 25: 47-52. 10.1016\/j.it.2003.10.012.","journal-title":"Trends Immunol"},{"key":"1335_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.crvi.2003.12.001","volume":"327","author":"R Castriconi","year":"2004","unstructured":"Castriconi R, Della Chiesa M, Morreta A: Shaping of adaptive immunity by innate interactions. C R Biol. 2004, 327: 533-537.","journal-title":"C R Biol"}],"container-title":["Arthritis Res Ther"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar1453\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:24:45Z","timestamp":1728383085000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar1453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,11]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1186\/ar1453","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,10]]},"assertion":[{"value":"13 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R30"}}